Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Monica B, Norton"'
Autor:
Jane L. Wang, Michael B. Tollefson, Margaret L. Grapperhaus, James A. Sikorski, Richard C. Durley, Monica B. Norton, Michele A. Promo, Michele A. Melton, Mark A. Massa, Emily J. Reinhard, Brian S. Hickory, William F. Vernier, Mark E. Smith, Yvette M. Fobian, Karen Regina, Bryan J. Witherbee, Daniel T. Connolly
Publikováno v:
Journal of Medicinal Chemistry. 46:2152-2168
A novel series of substituted N-[3-(1,1,2,2-tetrafluoroethoxy)benzyl]-N-(3-phenoxyphenyl)-trifluoro-3-amino-2-propanols is described which potently and reversibly inhibit cholesteryl ester transfer protein (CETP). Starting from the initial lead 1, va
Novel Terphenyls as Selective Cyclooxygenase-2 Inhibitors and Orally Active Anti-inflammatory Agents
Autor:
Peter C. Isakson, James J. Li, David B. Reitz, G. D. Anderson, Monica B. Norton, Carol M. Koboldt, Jaime L. Masferrer, Gregory Susan A, Emily J. Reinhard, Karen Seibert, Yan Zhang, Ben S. Zweifel, William Perkins
Publikováno v:
Journal of Medicinal Chemistry. 39:1846-1856
A novel series of terphenyl methyl sulfones and sulfonamides have been shown to be highly potent and selective cyclooxygenase-2 (COX-2) inhibitors. The sulfonamide analogs 17 and 21 were found to be much more potent COX-2 inhibitors and orally active
Autor:
E. Ann Hallinan, David B. Reitz, Timothy J. Hagen, Sofya Tsymbalov, James J. Li, R. Alan Chrusciel, Monica B. Norton
Publikováno v:
Journal of Heterocyclic Chemistry. 31:1689-1696
Lithiation of 8-chlorodibenz[b,f][1,4]oxazepine-10-tert-butylcarbamate (1) is described. Electrophilic substitution of the resulting N-Boc dibenzoxazepine α- lithioamine 2 with ketones, aldehydes, nitriles, iso-cyanates and imines, followed by an in
Autor:
Maria A. Palomo, Danny J. Garland, Konrad F. Koehler, David B. Reitz, Monica B. Norton, Emily J. Reinhard, Gillian M. Olins, Susan T. Chen, Robert E. Manning, J. T. Collins, Ellen G. McMahon
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 3:1055-1060
The surmountable (competitive) N 1 -(2-methylphenyl)-2H-imidazol-2-one angiotensin II receptor antagonist SC-54628 is converted to an insurmountable (noncompetitive) antagonist SC-54629 by the addition of a methyl group at the 6-position of the pheny
Autor:
Monica B. Norton, Maria A. Palomo, David B. Reitz, Ellen G. McMahon, V. M. Corpus, Mark A. Penick, Gillian M. Olins, D. E. Mcgraw, Emily J. Reinhard
Publikováno v:
ChemInform. 25
Autor:
David B. Reitz, Monica B. Norton, E. A. Hallinan, S. Tsymbalov, Timothy J. Hagen, James J. Li, R. A. Chrusciel
Publikováno v:
ChemInform. 26
Autor:
Carol M. Koboldt, Yan Zhang, Horng Chih Huang, Gregory Susan A, Danny J. Garland, Peter C. Isakson, A. W. Veenhuizen, Mark A. Penick, Monica B. Norton, David B. Reitz, Emily J. Reinhard, J. T. Collins, Karen Seibert, James J. Li
Publikováno v:
ChemInform. 26
Autor:
Peter C. Isakson, E. G. Burton, Monica B. Norton, A. W. Veenhuizen, Karen Seibert, David B. Reitz, H.‐C. Huang, William Perkins, Yan Zhang, J. L. Li, Emily J. Reinhard, Carol M. Koboldt, Gregory Susan A, J. N. Cogburn, G. D. Anderson, Eugene W. Logusch, Danny J. Garland, J. T. Collins
Publikováno v:
ChemInform. 27
Autor:
Karen Seibert, Emily J. Reinhard, G. D. Anderson, David B. Reitz, William Perkins, Yan Zhang, Carol M. Koboldt, Gregory Susan A, James J. Li, Ben S. Zweifel, Monica B. Norton, Peter C. Isakson, Jaime L. Masferrer
Publikováno v:
ChemInform. 27
A novel series of terphenyl methyl sulfones and sulfonamides have been shown to be highly potent and selective cyclooxygenase-2 (COX-2) inhibitors. The sulfonamide analogs 17 and 21 were found to be much more potent COX-2 inhibitors and orally active
Autor:
Olga V. Nemirovskiy, Mihir D. Parikh, Monica B. Norton, Jay M. Wendling, Michael S. Davies, Robert J. Mourey, Lakshman E. Rajagopalan, Toni A. Steiner, Ben S. Zweifel, Hideaki Shimada, Christine M. Kornmeier, Thomas P. Misko, Jaime L. Masferrer, Maria A. Payne, Larry E. Kahn, Stephen A. Kolodziej, Richard F Loeffler, Brenda L. Case
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 333(3)
Rho kinase, is the most widely studied downstream effector of the small Rho GTPase RhoA. Two Rho kinase isoforms have been described and are frequently referred to in the literature as ROCK1 and ROCK2. The RhoA-Rho kinase pathway has been implicated